Cardioprotective and anti-hypertensive effects of Prosopis glandulosa in rat models of pre-diabetes

Cardiovascular Journal of Africa

Volumn 24, Issue 2, 2013, Pages 10-16

  Samen, B Hui ^a,b   George, C ^b   Dietrich, D ^c   Genade, S ^a  

^a MRC DDP ^*  (South Africa)

^b UNIVERSITY OF STELLENBOSCH   (South Africa)

^c UNIVERSITY OF THE WESTERN CAPE   (South Africa)

Author keywords

Cardioprotection; Hypertension; Insulin resistance; PKB; Prosopis glandulosa

Indexed keywords

ANTIHYPERTENSIVE AGENT; CAPTOPRIL; HERBACEOUS AGENT; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BIOMETRY; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EX VIVO STUDY; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PERFUSION; HEART PROTECTION; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INGESTION; KNOCKOUT MOUSE; LIPID DIET; MALE; NONHUMAN; OBESITY; PROSOPIS GLANDULOSA; PROTEIN ANALYSIS; RAT; SIGNAL TRANSDUCTION; URINE VOLUME; WATER RETENTION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; FABACEAE; FRUIT; HYPERTENSION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; MYOCARDIUM; PHOSPHATIDYLINOSITOL 3-KINASE; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; PREDIABETIC STATE; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; RECEPTOR, INSULIN; TIME FACTORS; URINATION;

EID: 84875906024     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: 10.5830/CVJA-2012-069     Document Type: Article

References (29)

1. Felger RS. Mesquite in Indian cultures of the Southwestern North America. In Simpson BB (ed). Mesquite: Its Biology in Two Desert Scrub Ecosystems. Stroudsburg, PA: Dowden, Hutchinson & Ross, 1977: 150-176.
2. Harden ML, Zolfaghari R. Nutritive composition of green and ripe pods of honey mesquite (Prosopis glandulosa, Fabaceae). Econom Bot 1988; 42: 522-532.
3. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Third report of the NCEP - Adult Treatment panel III, final report. Circulation 2002; 106: 3143-3421.
4. Balkau B, Charles MA. Comment on the provisional report from the WHO Consultation. European Group for the Study of Insulin Resistance (EGIR). Diabetes Med 1999: 16: 442-443.
5. Factsheet of the World Health Organisation 2011; www.who.int/mediacentre.
6. Rader DJ. Effect of insulin resistance, dyslipidemia and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. Am J Med 2007; 120: S12-S18.
7. Malviya N, Jain S, Malviya S. Antidiabetic potential of medicinal plants. Acta Poloniae Pharmaceut - Drug Res 2010; 67: 113-118.
8. George C, Huisamen B, Lochner A. The efficacy of Prosopis glandulosa as antidiabetic treatment in rat models of diabetes and insulin resistance. J Ethnopharm 2011; 137: 298-304.
9. Samoylenko V, Ashfaq MK, Jacob M, et al. Indolizidine, anti-infective and antiparasitic compounds from Prosopis glandulosa var. glandulosa. J Natl Prod 2009; 72: 92-98.
10. Huisamen B, Genis A, Lochner A. Pre-treatment with a DPP-4 inhibitor is infarct sparing in hearts from obese, pre-diabetic rats. Cardiovasc Drugs Ther 2011; 25: 13-20.
11. Naderali EK, Pickavance LC, Wilding JPH, Williams G. Diet-induced endothelial dysfunction in the rat is independent of the degree of increase in total body weight. Clin Sci 2001; 100: 635-641.
12. Srinivastan K, Biswanad B, Asrat L, Kaul CL, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening. Pharm Res 2005; 52: 313-320.
13. Pickavance LC, Tadayyon M, Widdowson PS, Buckinham RE, Wilding JPH. Therapeutic index for rosiglitazone in dietary obese rats: separation of efficacy and haemodilution. Br J Pharm 1999; 128: 1570-1576.
14. Belke DD, Betuing S, Tuttle MJ, et al. Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J Clin Invest 2002; 109: 629-639.
15. Lochner A, Genade S, Moolman JA. Ischemic preconditioning: infarct size is a more reliable endpoint than functional recovery. Basic Res Cardiol 2003; 98: 337-346.
16. Bradford MM, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Ann Biochem 1976; 72: 248-254.
17. Ross AH, Gericke A. Phosphorylation keeps PTEN phosphatase closed for business. Proc Nat Acad Sci 2009; 106: 1297-1298.
18. Oudit GY, Penninger JM. Cardiac regulation by phosphoinositide 3-kinases and PTEN. Cardiovasc Res 2009; 82: 250-260.
19. Kurukulasuriya LR, Stas S, Lastra G, Manrique C, Sowers Jr. Hypertension in obesity. Med Clin North Am 2011; 95: 903-917.
20. Franssen R, Monajemi H, Stroes ES, Kastelein JJ. Obesity and dyslipidemia. Med Clin North Am 2011; 95: 893-902.
21. Mentreddy SRS, Mohamed AI, Rimando AM. Medicinal plants with hypoglycemic/anti-hyperglycemic properties: A review. Proc Assoc Adv Indust Crops Conf 2005; 20; 341-353.
22. Hausenloy DJ, Tsang A, Mocanu MM, Yellon DM. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol Heart Circulat Physiol 2005; 288: H971-H976.
23. Jonassen AK, Sack MN, Mjøs OD, Yellon DM. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res 2001; 89: 1191-1198.
24. Di R, Wu X, Chang Z, Zhao X, et al. S6K inhibition renders cardiac protection against myocardial infarction through PDK1 phosphorylation of Akt. Biochem J 2012; 441: 199-207
25. Huisamen B, Donthi, Lochner A. Insulin in combination with vanadate stimulates glucose transport in isolated cardiomyocytes from obese Zucker rats. Cardiovasc Drugs Ther 2001; 15: 445-452.
26. Ahloulay M, Schmitt F, Déchaux M, Bankir L. Vasopressin and urinary concentrating activity in diabetes mellitus. Diabetes Metab 1999; 25: 213-22.
27. De Paula RB, Da Silva AA, Hall E. Aldosterone Antagonism Attenuates Obesity-Induced Hypertension and glomerular hyperfiltration. Hypertension 2004; 43: 41-47.
28. Hall JE, Brands MW, Dixon WN, Smith Jr NJ. Obesity-induced hypertension, Renal function and systemic hemodynamics. Hypertension 1993; 22: 292-299.
29. Lee HB, Blaufox MD. Blood volume in the Rat. J Nucl Med 1985; 25: 72-76.